Gupta, Aditya K.
Versteeg, Sarah G.
Shear, Neil H.
Piguet, Vincent
Tosti, Antonella
Piraccini, Bianca Maria
Article History
First Online: 19 November 2018
Compliance with Ethical Standards
:
: No funding was received for the writing of this manuscript.
: Dr. A.K. Gupta is a clinical trials investigator and speaker for Valeant Canada, and a clinical trials investigator for Moberg. S.G. Versteeg is employed by Mediprobe Research Inc., a site where clinical trials are run under supervision of Dr. A.K. Gupta. Dr. V. Piguet reports receiving educational grants in his role as Department Division Director, Dermatology, University of Toronto (on behalf of the Division of Dermatology Residency Program) from Abbvie, Celgene, Janssen, Naos, Lilly, Sanofi, and Valeant, and non-financial support from La Roche-Posay, outside the submitted work. Dr. B.M. Piraccini has received consulting fees and/or honoraria from Isdin, Pfizer, and Polichem. Dr. N.H. Shear and Dr. A. Tosti have no conflicts to declare.